Prescription drug · NDA
Cycloset (bromocriptine mesylate) NDC 73515-123
Bromocriptine mesylate .8 mg/1 · Tablet · Oral · Avvisto Therapeutics LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 73515-123-21 | 73515012321 | 21 TABLET in 1 BOTTLE (73515-123-21)Marketed from May 23, 2024 | |
| 73515-123-30 | 73515012330 | 200 TABLET in 1 BOTTLE (73515-123-30)Marketed from May 23, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Cycloset
- Generic name (nonproprietary)
- bromocriptine mesylate
- Active ingredients
- Bromocriptine mesylate — .8 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Avvisto Therapeutics LLC
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020866
- Marketing start
- Listing expires
- Other FDA classes
- Ergolines (Chemical structure)
- Identifiers
- Product ID 73515-123_d584b098-e98a-4453-aa48-9d79a470036cSPL ID d584b098-e98a-4453-aa48-9d79a470036cSPL set ID e42ba916-16b9-4d1c-8d09-9d2fbb1b6c20RxCUI 859077, 859081UNII FFP983J3OD
- Pharmacologic class
- Ergot Derivative
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N473515012321followed by a unit qualifier and the quantityPackage 73515-0123-21. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
CYCLOSET is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. CYCLOSET is an ergot derivative indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) Limitations of Use: Should not be used to treat type 1 diabetes or diabetic ketoacidosis. ( 1 ) Limited efficacy data in combination with thiazolidinediones. ( 1 ) Efficacy has not been confirmed in combination with insulin. ( 1 ) Limitations of Use CYCLOSET should not be used to treat type 1 diabetes or diabetic ketoacidosis. Limited efficacy data in combination with thiazolidinediones. Efficacy has not been confirmed…
Excerpt only. Read the full label for complete information.